2020
DOI: 10.1007/s00330-020-06991-7
|View full text |Cite
|
Sign up to set email alerts
|

Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers

Abstract: Objectives To investigate whether radiomics features extracted from MRI of BRCA-positive patients with sub-centimeter breast masses can be coupled with machine learning to differentiate benign from malignant lesions using model-free parameter maps. Methods In this retrospective study, BRCA-positive patients who had an MRI from November 2013 to February 2019 that led to a biopsy (BI-RADS 4) or imaging follow-up (BI-RADS 3) for sub-centimeter lesions were included. Two radiologists assessed all lesions indepen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 33 publications
(21 citation statements)
references
References 30 publications
1
19
1
Order By: Relevance
“…They found that the model based on radiomics features from T2-w, DKI and quantitative DCE pharmacokinetic parameter maps had the best discriminatory ability for benign and malignant breast lesions (AUC = 0.921) [33]. Radiomics coupled to machine learning analysis applied to DCE-MRI, including both radiomics features and clinical data, also proved to be accurate in the characterization of < 1 cm breast lesions in ninety-six high-risk BRCA mutation carriers, with a diagnostic accuracy of 81.5%, signi cantly higher than qualitative morphological assessment with BI-RADS classi cation (AUC 53.4%) [37]. The usefulness of a multiparametric MRI approach was explored in a recent study by Tsarouchi et al [38].…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…They found that the model based on radiomics features from T2-w, DKI and quantitative DCE pharmacokinetic parameter maps had the best discriminatory ability for benign and malignant breast lesions (AUC = 0.921) [33]. Radiomics coupled to machine learning analysis applied to DCE-MRI, including both radiomics features and clinical data, also proved to be accurate in the characterization of < 1 cm breast lesions in ninety-six high-risk BRCA mutation carriers, with a diagnostic accuracy of 81.5%, signi cantly higher than qualitative morphological assessment with BI-RADS classi cation (AUC 53.4%) [37]. The usefulness of a multiparametric MRI approach was explored in a recent study by Tsarouchi et al [38].…”
Section: Discussionmentioning
confidence: 95%
“…Several studies have been published on the use of AI applied to MRI for breast cancer diagnosis, mainly aiming at increasing its relatively low speci city, compared to the high sensitivity, with accuracy values ranging from 0.728 to 0.920 [33][34][35][36][37]. Similar to our work, the group of Zhang et al also explored the possibility to improve the accuracy of the ML classi er combining radiomics features extracted from both morphological and functional contrast-enhanced and diffusion kurtosis MRI images of 207 histologically proven breast lesions.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have been published on the use of AI applied to MRI for breast cancer diagnosis, mainly aiming at increasing its relatively low specificity compared to its high sensitivity, with accuracy values ranging from 72.8 to 92.0% [40][41][42][43][44]. Similar to our work, Zhang et al also explored the possibility to improve the accuracy of the ML classifier combining radiomics features extracted from both morphological and functional DCE and diffusion kurtosis (DK) images of 207 histologically proven breast lesions.…”
Section: Discussionmentioning
confidence: 99%
“…Gibbs et al [ 44 ] evaluated the utility of radiomics analysis for breast cancer diagnosis in small breast lesions (BI-RADS 4/5) using radiomics DCE-based parameter maps and achieved an AUC of 0.78. Lo Gullo et al [ 45 ] focused on the characterization of subcentimeter breast masses (BI-RADS 3/4) in high-risk patients. Radiomics analysis coupled with machine learning showed a diagnostic accuracy of 81.5%, improving lesion characterization compared with radiologists’ BI-RADS classification.…”
Section: Discussionmentioning
confidence: 99%